Anticoagulants Market to Experience Growth of 8% CAGR During 2020 to 2026
Verfasser: ashwani_kailiya on Friday, 13 March 2020Thrombosis conditions have been thought to be a major cause of deaths and disabilities around the world, and anticoagulant products are key to treatment and prevention of such ailments. Some of the most commonly used types of anticoagulants include unfractionated heparin and vitamin K antagonists including warfarin.
Overall, the global anticoagulants market is projected to display a healthy rate of growth owing to a CAGR anticipated to reach ~ 8 per cent through the forecast period till 2026. The growth can be attributed to a number of factors such as increasing research and development activities, the rising numbers of online pharmacies, poor lifestyles, and the growing incidences of heart attacks, which increase the demand for anticoagulant products.
XA Inhibitors Gain Traction in North America, Asia Sticks to Heparins
The anticoagulant market within North America is expected to be largely driven by incidences of heart attacks and atrial fibrillation. Consequently, XA inhibitors have rapidly become the drug of choice for treatment and prevention in the region. This trend is supported by the growing and high rate of obesity in both the United States and Canada.
Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=4335